A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy
for Acute Myeloid Leukemia
Drug: Venetoclax
24 locations incl. Los Angeles
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06456463·Phase 2·Recruiting